Companies: 10,795·Total market cap: $144.5T

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.

RARENASDAQHealthcare● Active

$21.59

$-0.32(-1.46%)

Market Cap$2.1B

P/E Ratio—

52W High$42.37

52W Low$18.29

Avg Volume1.9M

Open$22.20

Beta0.38

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Ultragenyx Pharmaceutical Inc.（RARE）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · RARE · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-6.11Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$669.4MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding98.6MShares outstanding history

Next EarningsAug 4, 2026Est.Earnings history

探索 Ultragenyx Pharmaceutical Inc. 数据

分析师预测$48 · Buy

股息不分红

营收$673.0M+20.13%

盈利EPS $-5.83+7.31%

财务快照

FY 2025Revenue$673.0M▲ +20.13% YoY

202320242025

FY 2025Net Income-$575.0M▼ 1.02% YoY

202320242025

FY 2025EPS$-5.83▲ +7.31% YoY

202320242025

TTM:Revenue: $669.4MNet Income: -$609.4MEPS: $-6.11View income statement →

分析师评级与目标价

Buy33 位分析师

Strong Buy

0

Buy

27

Hold

5

Sell

1

Strong Sell

0

12-Month Price Target

$26.00Low

$21.59Current

$48.36Avg Target上涨空间 123.99%

$67.00High

合计: 33 · 买入占比: 81.8%

根据过去 3 个月内 33 位华尔街分析师，RARE 共识评级为 Buy，12 个月平均目标价 $48.36 （较现价 $21.59 上涨空间 123.99%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Ultragenyx Pharmaceutical Inc.

$21.59-1.46%$2.1B #2

Ascentage Pharma Group International

$17.12-0.47%$397.9M #3

Apogee Therapeutics, Inc.

$83.01-4.50%$5.1B #4

$87.43-0.96%$4.3B #5

CG Oncology, Inc. Common stock

$54.40+1.27%$4.8B #6

Centessa Pharmaceuticals plc

$39.70+0.20%$6.1B

股票表现

1D-1.46%

1W-1.19%

1M-17.34%

3M+1.60%

YTD-6.13%

1Y-41.71%

5Y-76.90%

关于 Ultragenyx Pharmaceutical Inc.

CEOEmil D. Kakkis

IPO DateJan 31, 2014

Employees1,294

CountryUS

Websiteultragenyx.com

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative treatments for rare and ultra-rare genetic conditions. Its operations sp…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Ultragenyx Pharmaceutical Inc.（RARE）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 31, 2014 在 NASDAQ 上市。截至最近交易日，RARE 股价为 $21.59，市值约为 $2.1B。过去12个月累计回报 -41.71%，年初至今回报 -6.13%。

根据 33 位华尔街分析师，Ultragenyx Pharmaceutical Inc. 股票共识评级为Buy，12个月平均目标价为 $48.36。2025 财年 Ultragenyx Pharmaceutical Inc. 营收 $673.0M，净利润 -$575.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Ultragenyx Pharmaceutical Inc.（RARE）股价为 $21.59，在 NASDAQ 上市，52周区间为 $18.29 – $42.37。

RARE 最新股价RARE quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议